coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Didsbury Chorlton Park & Burnage PCN, Manchester (LAD) · Health Inequalities Profile

    PCN U78687 · NHS Greater Manchester Integrated Care Board · 4 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    44,515

    Registered population

    68.0% aged 18–64

    13.5%

    Aged 65+

    ICB 14.9% · England 17.9%

    31%

    Ethnic minority (non-White)

    17.3% Asian · England 9.6%

    17.4%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~7,796

    Core20 residents (est.)

    Resident basis; registered basis ~8,156 · see page 3

    4,889

    Hypertension register

    +9.17% in 3 yrs · England +5.60%

    489

    SMI register

    5.2% of Manchester (LAD)'s

    666

    COPD register

    Reviews +4.04% in 3 yrs

    Forecast to 2030

    5,866

    Hypertension patients, 2030

    +977 on today

    75.5%

    QRISK ≥20% on statins, 2030

    +3.50pp over 3 yrs

    3.8%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    59.9 pp
    Deprivation concentrated in two PCN practices.

    Core20 share spans 59.9 pp: David Medical Centre is at 60.7% and Kingsway Medical Practice at 51.6%, against 0.8% at Barlow Medical Centre.

    -6.3 pp
    Mental health physical checks fell over 2023-2025.

    Over 2023 to 2025, psychosis alcohol recording fell 6.3 pp (England +5.4 pp), while SMI BMI (-4.1 pp) and BP (-1.8 pp) also declined.

    91.3%
    Hypertension BP recording and control beat England.

    Recent BP recording reaches 91.3% (England 90.0%) and control to target is 71.2% (England 70.3%), though crude prevalence is 10.6% (England 15.2%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A working-age population of 44,515 coexists with 31% non-White residents across four practices

    Across 44,515 registered patients, 68.0% (30,290) are aged 18 to 64, compared with 68.9% in Manchester (LAD), 63.3% in NHS Greater Manchester ICB, and 62.7% in England. Patients aged 65 and over make up 13.5% (6,017), above Manchester (9.6%) but below the ICB (14.9%) and England (17.9%). Resident Census estimates show a 31% non-White population, led by 17.3% Asian / Asian British residents (Manchester 20.9%, ICB 13.6%, England 9.6%), reaching 24.9% at Kingsway Medical Practice. These Census estimates reflect usual residents rather than GP registers.

    Age profile

    0–1718.4%
    18–6468.0%
    65+13.5%

    65+: ICB 14.9%, England 17.9%

    Ethnicity

    White69.0%
    Asian17.3%
    Mixed5.7%
    Other4.5%
    Black3.5%

    Older people · falls rows are Manchester (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Manchester LA)2,3572,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)81.0%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)55.2%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Manchester LA)1,2811,0219552024/25
    Falls deaths, all ages, per 100,000 (Manchester LA)26.818.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    A 17.4% PCN Core20 share masks a 59.9 pp spread between practices

    The PCN Core20 share is 17.4%, below England (21.0%), NHS Greater Manchester ICB (40.7%) and Manchester (59.8%). A 0.95 pp difference against the 18.3% weighted practice share reflects differing bases. Across practices, Core20 deprivation spans 59.9 pp: David Medical Centre is at 60.7% (an estimated 4,470 patients), Kingsway Medical Practice is at 51.6% (an estimated 3,074 patients), Didsbury Medical Centre - Dr Whitaker is at 3.1%, and Barlow Medical Centre is at 0.8%. Concentrated Core20 deprivation suggests outreach could prioritise the two higher-share practices over uniform allocation.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    David60.7% · 4,470 patients
    Kingsway Medical51.6% · 3,074 patients
    Didsbury - Dr3.1% · 479 patients
    Barlow0.8% · 133 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    489

    SMI register

    1.06% recorded prevalence

    193

    Learning disability register

    0.42% recorded prevalence

    12

    Care homes, 318 beds

    In the PCN catchment

    8.7%

    Provide unpaid care

    Manchester (LAD), Census 2021

    Recorded learning disability prevalence is 0.4% (193 patients) and severe mental illness is 1.1% (489 patients), alongside 12 catchment care homes holding 318 beds. Borough-level rough sleeping (55 people in Manchester) and unpaid care (8.7%) describe the wider authority and cannot be extrapolated to GP lists. With severe mental illness prevalence at 1.1% (England 1.0%) and learning disability at 0.4% (England 0.6%), severe mental illness may represent a larger register.

    Severe mental illness: physical health checks

    Over 2023 to 2025, SMI checks fell: alcohol fell 6.3 pp (England +5.4 pp), BMI fell 4.1 pp (England +5.1 pp), and blood pressure fell 1.8 pp (England +4.4 pp). Blood pressure checks reached 62.9% at David Medical Centre.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    4,889

    Hypertension register

    +9.17%

    Register growth, 3 yrs

    Manchester (LAD) +4.49% · England +5.60%

    +2.92pp

    BP control, under 80

    ≤140/90 · +2.38pp aged 80+

    +977

    More patients by 2030

    Forecast 5,866 (12.58%)

    Hypertension case-finding and control

    Hypertension QOF prevalence is 10.6% (4,889 patients), compared to Manchester (10.5%), NHS Greater Manchester ICB (14.4%) and England (15.2%), with 3-year growth of +9.2% over 2023 to 2025 (England +5.6%). Blood pressure recording reaches 91.3% (England 90.0%) and overall treatment to target is 71.2% (England 70.3%). However, control among patients aged 80 and over is 79.8%, trailing England (81.2%) and the ICB (83.2%).

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy reached 67.9% (England 63.6%). However, statin treatment for diabetes patients aged 40 and over without CVD fell 2.4% over 2023 to 2025 (England +2.1%) to 74.4%.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202667,428£2.20£1.94£1.86£148,342
    Cardiovascular (all), 202591,362£2.54£3.15£3.33£232,059

    For lipid-modifying drugs in 2026, the PCN prescribed 67,428 items at £2.20 per item, compared to £1.86 in England and £1.94 in NHS Greater Manchester ICB, spending £22,926 more than at England's unit cost.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +16.27%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +5.23%

    Asthma prevalence, PCN 3-yr % change

    Asthma reviews rose +16.3% over 2023 to 2025 to 68.0%, above Manchester (67.0%), NHS Greater Manchester ICB (66.2%) and England (65.7%), yet an estimated 936 of 2,926 register patients lack a review. Youth asthma second-hand smoke recording is 74.2%, below Manchester (76.0%), the ICB (79.7%) and England (78.8%). COPD reviews stand at 67.6% across 666 register patients, below Manchester (74.5%), the ICB (76.4%) and England (76.4%). Structured respiratory recall should prioritise unreviewed asthma and COPD cohorts.

    Cancer register and children's immunisation

    Cancer prevalence is 3.2% (1,493 patients), compared to 2.2% in Manchester, 3.3% in NHS Greater Manchester ICB and 3.8% in England. For age-5 immunisations in Q1 2025/26, 4-in-1 booster coverage is 77.2% (below the 95.0% target by 17.8 pp) and MMR dose 2 is 85.9% (below target by 9.1 pp), with a 5.4 pp difference between first and second doses.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months91.7%

    England 91.0%

    6-in-1 complete primary course at 24 months93.1%

    England 92.2%

    MMR dose 1 at 24 months90.1%

    England 88.3%

    MMR dose 2 at age 585.9%

    England 82.8%

    4-in-1 pre-school booster at age 577.2%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    In 2022, 55.6% of staged cancers (6,491 of 11,679 with known stage) in NHS Greater Manchester ICB were diagnosed at stage 1 or 2, similar to England (55.3%) but 19.4 pp below the 75.0% national ambition, needing 2,268.2 extra early-stage diagnoses across the ICB. Known-stage coverage was 70.8% (11,679 of 16,492 registered cancers); missing stage limits direct inference and reflects system pathways rather than PCN delivery. Locally, PCN breast screening coverage is 63.1% (England 69.9%) despite a +20.1% rise over 2023 to 2024, with David Medical Centre at 49.3% and Kingsway Medical Practice at 55.8%. Targeted outreach at lower-uptake practices could improve early detection.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026, Manchester University NHS Foundation Trust achieved 72.8% on the 62-day cancer standard (12.2 pp below the 85.0% standard), behind Northern Care Alliance NHS Foundation Trust (78.6%), Stockport NHS Foundation Trust (74.7%), and NHS Greater Manchester Integrated Care Board (75.7%), but above England (71.2%). On the 28-day faster diagnosis standard (target 75.0%), Manchester University reached 80.1% (ICB 79.5%, England 79.3%). In diagnostics, Manchester University recorded 14.7% waiting 6+ weeks for Computed Tomography (England 9.9%). These trust figures reflect acute provider performance.

    Pathways within standard (%)ManchesterStockportNorthern Care AllianceGreater Manchester ICBEngland
    28-day faster diagnosis (75%)80.0683.2175.2079.5379.32
    31-day treatment (96%)92.5497.3994.5496.4992.50
    62-day referral to treatment (85%)72.8574.6778.6575.7371.16
    Diagnostic waits over 6 weeks (%)ManchesterStockportNorthern Care AllianceEngland
    MRI11.681.415.0921.40
    CT14.662.934.109.92
    Echocardiography4.9117.4631.4828.48
    Colonoscopy4.515.5340.0430.83
    Gastroscopy29.355.3136.4829.02
    All 15 DM01 tests8.9814.0815.7123.14
    Community services activityManchester residentsGreater Manchester ICB
    Care contacts96,995573,310
    Referrals20,27094,470
    Patients with a contact31,040183,535

    Community services (residents of Manchester), Jun 2026 (provisional). In Jun 2026, 43.3% of community service contacts among Manchester borough residents were with adults aged 65 and over (42,015 of 96,995 contacts). These provisional figures describe local authority residents rather than PCN-specific activity, highlighting substantial community service delivery directed toward older residents across the borough.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice vaccination achievement spans 84.4 percentage points alongside uneven telephone access

    In 2025/26, clinical-domain QOF achievement was near-total across all practices, between 99.9% and 100.0%. However, vaccination and immunisation achievement showed an 84.4 pp spread, from 15.6% at David Medical Centre and 40.7% at Kingsway Medical Practice to 100.0% at Didsbury Medical Centre - Dr Whitaker. Personalised care adjustments peaked at 17.2% at David Medical Centre.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Didsbury - Dr1113.171.2%85.9%87.5%
    Barlow940.849.2%71.2%80.8%
    Kingsway Medical7351.659.0%60.2%77.0%
    David11860.767.8%66.5%76.3%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNManchester (LAD)AssetPCNManchester (LAD)
    Care homes (catchment)12 (318 beds)n/aSchools (catchment)54n/a
    Children's centres434Places of worship34289
    Libraries216Homelessness support (VCS)n/a1
    Primary schools (LA maintained)668Primary academies550
    Special schoolsn/a3

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma and COPD recall

    An estimated 936 of 2,926 asthma patients lack an annual review (68.0% vs England 65.7%), and COPD reviews sit at 67.6% of 666 patients (England 76.4%). For discussion: the PCN could run a single-template respiratory recall and offer flexible clinic slots, starting in the highest-deprivation practices. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    SMI physical health check recovery

    Over 2023 to 2025 across 489 SMI patients, BP checks fell 1.8 pp to 82.0% (England 83.4%, +4.4 pp), BMI fell 4.1 pp, and alcohol recording fell 6.3 pp. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Targeted screening and booster catch-up

    Breast screening is 63.1% (England 69.9%; David Medical Centre 49.3%, Kingsway Medical Practice 55.8%). Age-5 4-in-1 coverage is 77.2% (below the 95.0% target by 17.8 pp) and MMR2 is 85.9% (below by 9.1 pp). Moderate effort to run.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Tailored communication outreach (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Targeted Core20 practice outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check recovery (p4)Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Older adult hypertension review (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school immunisation catch-up (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted breast screening recall (p7)Breast screening coverage: aged 53 to 70 years old—PCN
    Practice telephone access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma and COPD recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD registerCore20PLUS5 respiratoryPCN
    Option 2 · SMI physical health check recovery (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN & Practice
    Option 3 · Targeted screening and booster catch-up (p12)Breast screening coverage: aged 53 to 70 years old · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 5 · MMR dose 2 coverage at age 5—PCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15